3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV–infected mice

@pier_dole @MailOnline Neither true nor relevant https://t.co/Ksz1XHYBf5

RT @ferdevill: La OMS y el gobierno globalista lo niegan . Esto es lo que ocurre cuando la ciencia es manipulada por los políticos globalis…

La OMS y el gobierno globalista lo niegan . Esto es lo que ocurre cuando la ciencia es manipulada por los políticos globalistas... tengo la esperanza de que la sociedad despierte https://t.co/0NboLTqIch https://t.co/3MbMQ1h937

前からあるからな。まあいろいろ活性化するのはいいことだ。ていうか懐かしくもある😌🚬 https://t.co/XJDu70OE0d

RT @ms101phd: Hi Eric: fyi Kansas State University (KSURF) dream team of virologists were light years ahead of this new study below hence…

Hi Eric: fyi Kansas State University (KSURF) dream team of virologists were light years ahead of this new study below hence lead Cocrystal CDI-45205 $COCP https://t.co/UsQvboPAaD $COCP

@jjcouey these are the Pfizer "antiviral pills" NYT is talking about - https://t.co/8YSSBEGtqy - effective against SARS, MERS, and SARS-CoV-2 in mouse models - one compound shows 100% survival rate

The key to protease inhibition appears to be timing. Here, a study on mice shows quickly decreasing efficacy the longer the delay from infection to administration. (drop from 80% to 40% survival from 1 dpi to 2 dpi with their test inhibitor) 2/5 https://t

@stickfigures88 $cocp did have news like that. $hoth just published in vitro data where Cocrystal in vitro data was published last August in science mag. https://t.co/pyukXhY9CD

RT @G_Commish: Lots of discussion on protease this morning on @CNBC this morning. Remember 3CL protease excellent target https://t.co/9wej…

RT @G_Commish: Lots of discussion on protease this morning on @CNBC this morning. Remember 3CL protease excellent target https://t.co/9wej…

RT @G_Commish: Lots of discussion on protease this morning on @CNBC this morning. Remember 3CL protease excellent target https://t.co/9wej…

RT @G_Commish: Lots of discussion on protease this morning on @CNBC this morning. Remember 3CL protease excellent target https://t.co/9wej…

Lots of discussion on protease this morning on @CNBC this morning. Remember 3CL protease excellent target https://t.co/9wej4o3x6n

RT @blanc0981: TMPRSS２とかのセリンプロテアーゼでなく システインプロテアーゼの阻害 全身投与では多方面のプロテアーゼ阻害の治療が一番有望な気もする 局所では吸入ステロイド https://t.co/KuJgLvr6kG

RT @ms101phd: $COCP vs $AVIR https://t.co/UsQvboPAaD with Atea mkt cap 70x greater at the moment... #WarpSpeed

$COCP vs $AVIR https://t.co/UsQvboPAaD with Atea mkt cap 70x greater at the moment... #WarpSpeed

RT @ms101phd: $COCP CDI-45205 3CL *Protease Inhibitors https://t.co/UsQvboPAaD https://t.co/1Oh2Ysrcn3

$COCP CDI-45205 3CL *Protease Inhibitors https://t.co/UsQvboPAaD https://t.co/1Oh2Ysrcn3

@onthewall_fly @Morbillivirus https://t.co/2Js8WP5ClG

https://t.co/aQLUUqlSNT

@Gstoned1 @ms101phd $cocp Pfizer has PF-07304814 (Intravenous Only) which started P1 Sep 1. Our protease inhibitors are here https://t.co/pyukXhY9CD. Study includes Anivive's GC376, also licensed from KSurf, which should be starting P1 Trials in Dec.

$cocp I'm not sure I agree with the Imminent assessment but it is fun to say. I believe it is OTW. -Penny

$COCP ran $1.60- $4+ and traded over 50 million shares on COVID-19 study 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in SARS-COV-2 and NOW the COVID-19 Antiviral Drug **IMMINENT https://t.co/UsQvboPAaD

3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV–infected mice https://t.co/52B8PR042h Following the science What is cause of minimal virus replication in younger people? MERS in mice cured death 100% cure

3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV–infected mice Rathnayake; et. Science Translational Medicine  19 Aug 2020: Vol. 12, Issue 557, https://t.co/ZcuHkIOqR8

RT @ms101phd: $COCP THE ANTIVIRAL DRUG CURE TO SARS-COV-2 https://t.co/UsQvboPAaD 🔥

$COCP THE ANTIVIRAL DRUG CURE TO SARS-COV-2 https://t.co/UsQvboPAaD 🔥

RT @blanc0981: TMPRSS２とかのセリンプロテアーゼでなく システインプロテアーゼの阻害 全身投与では多方面のプロテアーゼ阻害の治療が一番有望な気もする 局所では吸入ステロイド https://t.co/KuJgLvr6kG

RT @blanc0981: TMPRSS２とかのセリンプロテアーゼでなく システインプロテアーゼの阻害 全身投与では多方面のプロテアーゼ阻害の治療が一番有望な気もする 局所では吸入ステロイド https://t.co/KuJgLvr6kG

RT @blanc0981: TMPRSS２とかのセリンプロテアーゼでなく システインプロテアーゼの阻害 全身投与では多方面のプロテアーゼ阻害の治療が一番有望な気もする 局所では吸入ステロイド https://t.co/KuJgLvr6kG

TMPRSS２とかのセリンプロテアーゼでなく システインプロテアーゼの阻害 全身投与では多方面のプロテアーゼ阻害の治療が一番有望な気もする 局所では吸入ステロイド https://t.co/KuJgLvr6kG

3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice. https://t.co/QiXBbU0r5R https://t.co/nses8y1ny6

RT @pcr_wada_com: Science Translational Medicine 8月3日 の論文は、コロナウイルスで保存性が高い3CL プロテアーゼ（新型コロナではnsp5）に対する低分子の阻害剤がウイルス感染を抑制できるか、MERS-CoVを使いマウスで解…

3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV–infected mice https://t.co/Nk0yC8cHn6

@MichaelKGilson @SciFinder https://t.co/eKnq3BN0z9 Maybe you could send those 6 SMILES from their Markush? (could not access supp dat) I think 6e is CCCC2CCC(OC(=O)NC(CC(C)C)C(=O)N[C@H](O)C[C@H]1CCNC1=O)CC2 6d is PDB lig QZG

RT @ms101phd: $COCP JUST RAN EASILY FROM $1-4 PRIOR TO THE COVID-19 MKT PARTNER WITH THIS SURPRISE WORLD REKNOWN PUBLICATION https://t.co/…

$COCP JUST RAN EASILY FROM $1-4 PRIOR TO THE COVID-19 MKT PARTNER WITH THIS SURPRISE WORLD REKNOWN PUBLICATION https://t.co/UsQvboPAaD

@buysellshort https://t.co/vhq87C7Sb7 Use of the University of Kansas Protein Structure Laboratory was supported by a grant from the National Institute of General Medical Sciences (P30GM110761) of the NIH

RT @ms101phd: $COCP 95% OF COVID-19 BIOTECH STOCKS ARE PR PROMO 1 DAY MARKETING MACHINES WITHOUT REAL SCIENCE DATA AS COCRYSTAL HAS THE REA…

RT @ms101phd: $COCP 95% OF COVID-19 BIOTECH STOCKS ARE PR PROMO 1 DAY MARKETING MACHINES WITHOUT REAL SCIENCE DATA AS COCRYSTAL HAS THE REA…

$COCP 95% OF COVID-19 BIOTECH STOCKS ARE PR PROMO 1 DAY MARKETING MACHINES WITHOUT REAL SCIENCE DATA AS COCRYSTAL HAS THE REAL SCIENCE AND INVESTORS WILL BE HANDSOMELY REWARDED!! https://t.co/UsQvboPAaD

RT @ms101phd: $COCP ALL COVID-19 ANTIVIRAL ROADS LEAD TO COCRYSTAL MULTI BILLION DOLLAR COMPOUNDS 10 YEAR HEAD START DEVELOPED BY THE (KSUR…

RT @ms101phd: $COCP ALL COVID-19 ANTIVIRAL ROADS LEAD TO COCRYSTAL MULTI BILLION DOLLAR COMPOUNDS 10 YEAR HEAD START DEVELOPED BY THE (KSUR…

RT @ms101phd: $COCP ALL COVID-19 ANTIVIRAL ROADS LEAD TO COCRYSTAL MULTI BILLION DOLLAR COMPOUNDS 10 YEAR HEAD START DEVELOPED BY THE (KSUR…

$COCP ALL COVID-19 ANTIVIRAL ROADS LEAD TO COCRYSTAL MULTI BILLION DOLLAR COMPOUNDS 10 YEAR HEAD START DEVELOPED BY THE (KSURF) DREAM TEAM OF THE TOP SCIENTISTS IN THE WORLD 👑 GUARANTEED https://t.co/UsQvboPAaD

3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV–infected mice https://t.co/glHFujXFb4

@CocrystalPharma $cocp https://t.co/zr1IQsveQ7 https://t.co/TDt3EUpbnG

@Shadow0pz I have a hunch he's going to announce FDA fast-tracking of protease inhibitors. There was a recent study that looks promising: https://t.co/nVoMnPltCr(3CLpro,vital%20role%20in%20coronavirus%20replication.&text=now%20report%20a%20series%20of,

3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV–infected mice https://t.co/bScCr7kU24

https://t.co/fsB02p5XQj

RT @pcr_wada_com: Science Translational Medicine 8月3日 の論文は、コロナウイルスで保存性が高い3CL プロテアーゼ（新型コロナではnsp5）に対する低分子の阻害剤がウイルス感染を抑制できるか、MERS-CoVを使いマウスで解…

https://t.co/ZG6a0IeWgz

RT @ms101phd: $COCP STARTING BID $2 BILLION OR $50 THAT MIGHT BE SERIOUSLY CONSIDERED HAVING "THE" LEADING COMPOUND 3CLPRO THAT KILLS SARS-…

$COCP

RT @ms101phd: $COCP STARTING BID $2 BILLION OR $50 THAT MIGHT BE SERIOUSLY CONSIDERED HAVING "THE" LEADING COMPOUND 3CLPRO THAT KILLS SARS-…

$COCP STARTING BID $2 BILLION OR $50 THAT MIGHT BE SERIOUSLY CONSIDERED HAVING "THE" LEADING COMPOUND 3CLPRO THAT KILLS SARS-COV-2 @GileadSciences @GSK @Roche @JNJInnovation @Merck @NovartisScience @Regeneron @LillyPad @sanofi @pfizer @Novartis https://t.

RT @ms101phd: $COCP PROVEN TO KILL SARS-COV-2 3CLPRO (IN PROGRESS) COVID-19 MARKETING PARTNER BID WAR 🔬@GileadSciences @GSK @Roche @JNJInn…

RT @ms101phd: $COCP PROVEN TO KILL SARS-COV-2 3CLPRO (IN PROGRESS) COVID-19 MARKETING PARTNER BID WAR 🔬@GileadSciences @GSK @Roche @JNJInn…

RT @ms101phd: $COCP PROVEN TO KILL SARS-COV-2 3CLPRO (IN PROGRESS) COVID-19 MARKETING PARTNER BID WAR 🔬@GileadSciences @GSK @Roche @JNJInn…

RT @ms101phd: $COCP PROVEN TO KILL SARS-COV-2 3CLPRO (IN PROGRESS) COVID-19 MARKETING PARTNER BID WAR 🔬@GileadSciences @GSK @Roche @JNJInn…

$COCP PROVEN TO KILL SARS-COV-2 3CLPRO (IN PROGRESS) COVID-19 MARKETING PARTNER BID WAR 🔬@GileadSciences @GSK @Roche @JNJInnovation @Merck @NovartisScience @Regeneron https://t.co/ZwLYigaqtj

RT @pcr_wada_com: Science Translational Medicine 8月3日 の論文は、コロナウイルスで保存性が高い3CL プロテアーゼ（新型コロナではnsp5）に対する低分子の阻害剤がウイルス感染を抑制できるか、MERS-CoVを使いマウスで解…

RT @pcr_wada_com: Science Translational Medicine 8月3日 の論文は、コロナウイルスで保存性が高い3CL プロテアーゼ（新型コロナではnsp5）に対する低分子の阻害剤がウイルス感染を抑制できるか、MERS-CoVを使いマウスで解…

RT @pcr_wada_com: Science Translational Medicine 8月3日 の論文は、コロナウイルスで保存性が高い3CL プロテアーゼ（新型コロナではnsp5）に対する低分子の阻害剤がウイルス感染を抑制できるか、MERS-CoVを使いマウスで解…

RT @pcr_wada_com: Science Translational Medicine 8月3日 の論文は、コロナウイルスで保存性が高い3CL プロテアーゼ（新型コロナではnsp5）に対する低分子の阻害剤がウイルス感染を抑制できるか、MERS-CoVを使いマウスで解…

RT @pcr_wada_com: Science Translational Medicine 8月3日 の論文は、コロナウイルスで保存性が高い3CL プロテアーゼ（新型コロナではnsp5）に対する低分子の阻害剤がウイルス感染を抑制できるか、MERS-CoVを使いマウスで解…

RT @pcr_wada_com: Science Translational Medicine 8月3日 の論文は、コロナウイルスで保存性が高い3CL プロテアーゼ（新型コロナではnsp5）に対する低分子の阻害剤がウイルス感染を抑制できるか、MERS-CoVを使いマウスで解…

RT @pcr_wada_com: Science Translational Medicine 8月3日 の論文は、コロナウイルスで保存性が高い3CL プロテアーゼ（新型コロナではnsp5）に対する低分子の阻害剤がウイルス感染を抑制できるか、MERS-CoVを使いマウスで解…

RT @pcr_wada_com: Science Translational Medicine 8月3日 の論文は、コロナウイルスで保存性が高い3CL プロテアーゼ（新型コロナではnsp5）に対する低分子の阻害剤がウイルス感染を抑制できるか、MERS-CoVを使いマウスで解…

RT @pcr_wada_com: Science Translational Medicine 8月3日 の論文は、コロナウイルスで保存性が高い3CL プロテアーゼ（新型コロナではnsp5）に対する低分子の阻害剤がウイルス感染を抑制できるか、MERS-CoVを使いマウスで解…

RT @pcr_wada_com: Science Translational Medicine 8月3日 の論文は、コロナウイルスで保存性が高い3CL プロテアーゼ（新型コロナではnsp5）に対する低分子の阻害剤がウイルス感染を抑制できるか、MERS-CoVを使いマウスで解…

RT @pcr_wada_com: Science Translational Medicine 8月3日 の論文は、コロナウイルスで保存性が高い3CL プロテアーゼ（新型コロナではnsp5）に対する低分子の阻害剤がウイルス感染を抑制できるか、MERS-CoVを使いマウスで解…

Science Translational Medicine 8月3日 の論文は、コロナウイルスで保存性が高い3CL プロテアーゼ（新型コロナではnsp5）に対する低分子の阻害剤がウイルス感染を抑制できるか、MERS-CoVを使いマウスで解析。抗ウイルス剤として、今後発展することを期待しています。 https://t.co/PNyFGj6onx

RT @ScienceMagazine: A series of broad antiviral compounds that kill #SARSCoV2 and MERS-CoV could be developed into badly needed treatments…

RT @ScienceMagazine: A series of broad antiviral compounds that kill #SARSCoV2 and MERS-CoV could be developed into badly needed treatments…

RT @ScienceMagazine: A series of broad antiviral compounds that kill #SARSCoV2 and MERS-CoV could be developed into badly needed treatments…

RT @ms101phd: $COCP ADVANCED DISCUSSIONS WITH STRATEGIC #COVID19 PARTNERS WITH THE ONLY COMPOUNDS THAT ARE PROVEN TO KILL SARS-COV-2 DETAIL…

RT @ms101phd: $COCP ADVANCED DISCUSSIONS WITH STRATEGIC #COVID19 PARTNERS WITH THE ONLY COMPOUNDS THAT ARE PROVEN TO KILL SARS-COV-2 DETAIL…

RT @vicatallah: Compuestos antivirales de nueva ingeniería basados en inhibición de enzima viral crítica llamada proteasa similar a 3C pued…

RT @vicatallah: Compuestos antivirales de nueva ingeniería basados en inhibición de enzima viral crítica llamada proteasa similar a 3C pued…

RT @ms101phd: $COCP ADVANCED DISCUSSIONS WITH STRATEGIC #COVID19 PARTNERS WITH THE ONLY COMPOUNDS THAT ARE PROVEN TO KILL SARS-COV-2 DETAIL…

$COCP ADVANCED DISCUSSIONS WITH STRATEGIC #COVID19 PARTNERS WITH THE ONLY COMPOUNDS THAT ARE PROVEN TO KILL SARS-COV-2 DETAILED IN THIS PRESTIGIOUS PUBLICATION...LET THE BIDDING WAR BEGIN 🔬 CC: $GILD $MRK $REGN @GileadSciences @Merck @Regeneron https://t.

RT @vicatallah: Compuestos antivirales de nueva ingeniería basados en inhibición de enzima viral crítica llamada proteasa similar a 3C pued…

RT @ScienceMagazine: A series of broad antiviral compounds that kill #SARSCoV2 and MERS-CoV could be developed into badly needed treatments…

RT @vicatallah: Compuestos antivirales de nueva ingeniería basados en inhibición de enzima viral crítica llamada proteasa similar a 3C pued…

RT @vicatallah: Compuestos antivirales de nueva ingeniería basados en inhibición de enzima viral crítica llamada proteasa similar a 3C pued…

RT @vicatallah: Compuestos antivirales de nueva ingeniería basados en inhibición de enzima viral crítica llamada proteasa similar a 3C pued…

RT @vicatallah: Compuestos antivirales de nueva ingeniería basados en inhibición de enzima viral crítica llamada proteasa similar a 3C pued…

RT @vicatallah: Compuestos antivirales de nueva ingeniería basados en inhibición de enzima viral crítica llamada proteasa similar a 3C pued…

RT @vicatallah: Compuestos antivirales de nueva ingeniería basados en inhibición de enzima viral crítica llamada proteasa similar a 3C pued…

RT @vicatallah: Compuestos antivirales de nueva ingeniería basados en inhibición de enzima viral crítica llamada proteasa similar a 3C pued…

RT @ScienceMagazine: A series of broad antiviral compounds that kill #SARSCoV2 and MERS-CoV could be developed into badly needed treatments…

RT @vicatallah: Compuestos antivirales de nueva ingeniería basados en inhibición de enzima viral crítica llamada proteasa similar a 3C pued…

RT @vicatallah: Compuestos antivirales de nueva ingeniería basados en inhibición de enzima viral crítica llamada proteasa similar a 3C pued…

RT @vicatallah: Compuestos antivirales de nueva ingeniería basados en inhibición de enzima viral crítica llamada proteasa similar a 3C pued…

RT @vicatallah: Compuestos antivirales de nueva ingeniería basados en inhibición de enzima viral crítica llamada proteasa similar a 3C pued…

Compuestos antivirales de nueva ingeniería basados en inhibición de enzima viral crítica llamada proteasa similar a 3C pueden neutralizar el SARS-CoV-2, virus que causa COVID-19, en las células de vías respiratorias humanas #VEA https://t.co/IIT2mzVZ6A

RT @ms101phd: $COCP $GILD $PFE PFIZER AGREEMENT WITH GILEAD TO MANUFACTUE AND SUPPLY THE COVID-19 ANVIRAL REMDESIVIR WHICH IS ALSO BEING TE…

RT @ms101phd: $COCP $GILD $PFE PFIZER AGREEMENT WITH GILEAD TO MANUFACTUE AND SUPPLY THE COVID-19 ANVIRAL REMDESIVIR WHICH IS ALSO BEING TE…